Exciting new developments in proton therapy treatments

PDL1 expression in thymic tumours

Exciting update on the Repurposing Drugs in Oncology (ReDO) project

EHA 2015: Reviewing the treatment landscapes of CLL, MCL, and MM

Applications of chimaeric antigen receptor T-cells in leukaemia

Minimal residual disease in multiple myeloma

Immunoconjugates address unmet needs in Hodgkin's lymphoma patients

EHA 2015: Expert opinions on new treatment standard in multiple myeloma

Exploring "bad luck" - why do some patients develop myeloid leukaemia?

Genomic sequencing to find AML-causing mutations

The latest in multiple myeloma: a European and US perspective

Measuring molecular responses to tyrosine kinase inhibitors in chronic myeloid leukaemia